2-106415903-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001144013.2(RGPD3):c.5011G>A(p.Gly1671Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000236 in 1,611,670 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001144013.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RGPD3 | NM_001144013.2 | c.5011G>A | p.Gly1671Ser | missense_variant | 21/23 | ENST00000409886.4 | NP_001137485.1 | |
RGPD3 | XM_017004738.2 | c.5035G>A | p.Gly1679Ser | missense_variant | 22/24 | XP_016860227.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RGPD3 | ENST00000409886.4 | c.5011G>A | p.Gly1671Ser | missense_variant | 21/23 | 1 | NM_001144013.2 | ENSP00000386588 | P2 | |
RGPD3 | ENST00000304514.11 | c.4993G>A | p.Gly1665Ser | missense_variant | 21/23 | 2 | ENSP00000303659 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 151974Hom.: 0 Cov.: 27
GnomAD3 exomes AF: 0.0000601 AC: 15AN: 249640Hom.: 0 AF XY: 0.0000370 AC XY: 5AN XY: 135196
GnomAD4 exome AF: 0.0000233 AC: 34AN: 1459696Hom.: 0 Cov.: 40 AF XY: 0.0000165 AC XY: 12AN XY: 726156
GnomAD4 genome AF: 0.0000263 AC: 4AN: 151974Hom.: 0 Cov.: 27 AF XY: 0.0000270 AC XY: 2AN XY: 74200
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 09, 2024 | The c.5011G>A (p.G1671S) alteration is located in exon 21 (coding exon 21) of the RGPD3 gene. This alteration results from a G to A substitution at nucleotide position 5011, causing the glycine (G) at amino acid position 1671 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at